Pharmaceutical

RioDerm-004 by Rion for Fistula: Likelihood of Approval

RioDerm-004 is under clinical development by Rion and currently in Phase I for Fistula.

Feb 20, 2024 - 18:00
RioDerm-004 is under clinical development by Rion and currently in Phase I for Fistula.
Read the original article

Tags:

Previous Article

Not Disclosed Neurodegeneration by Eli Lilly and Co for Neurodegenerative Diseas...

Next Article

RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihood of Approval

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Delay of eye drop recall highlights FDA’s impotence on the issue

STAT+: Delay of eye drop recall highlights FDA’s impote...

Nov 21, 2023

How a supplement company became a haven for health misinformation

How a supplement company became a haven for health misi...

Sep 8, 2023

Opinion: RSV vaccine approval should be a top priority for the FDA

Opinion: RSV vaccine approval should be a top priority ...

Apr 19, 2023